Youth substance use is associated with increased risk for delinquency, academic underachievement, teen pregnancy, sexually transmitted infections, perpetrating or experiencing violence, injuries, and mental health problems (U.S. Department of Health and Human Services 2016). Preventing or delaying substa...
The American Society of Addiction Medicine (ASAM) and the American Academy of
Addiction Psychiatry (AAAP) developed this Clinical Practice Guideline on the Management
of Stimulant Use Disorder (hereafter referred to as the Guideline) to provide evidence-based
strategies and standards of care for the trea...
This guideline covers targeted interventions to prevent misuse of drugs, including illegal drugs, ‘legal highs’ and prescription-only medicines. It aims to prevent or delay harmful use of drugs in children, young people and adults who are most likely to start using drugs or who are already experiment...
These guidelines aim to provide a strategic approach to reducing morbidity and mortality related to TB and HIV among at-risk drug users and their communities in a way that promotes holistic and person-centered services. They are intended for professionals dealing with the drug users who have the most pro...
mhGAP is WHO’s action plan to scale up services for mental, neurological and substance use disorders for countries especially with low and lower middle incomes. The priority conditions addressed by mhGAP are: depression, schizophrenia and other psychotic disorders, suicide, epilepsy, dementia, disorder...
